VISTAGEN THERAPEUTICS, INC. (VTGN) Net margin 2017–2026
VISTAGEN THERAPEUTICS, INC. (VTGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-5491.3%FY2026 · since FY2017: -820.4% → -5491.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -5491.3% | +5088.5 pp |
| FY2025 | -10579.8% | -7820.2 pp |
| FY2024 | -2759.6% | — |
| FY2022 | -4306.8% | -2660.7 pp |
| FY2021 | -1646.1% | — |
| FY2017 | -820.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VTGN financial trends
VTGN RevenueVTGN Net incomeVTGN Gross profitVTGN Gross marginVTGN Operating incomeVTGN Operating marginVTGN Operating cash flowVTGN Free cash flowVTGN Capital expendituresVTGN Return on equityVTGN Stock buybacksVTGN Dividends paidVTGN Total assetsVTGN Total liabilitiesVTGN Shareholders’ equityVTGN overview →